TABLE 1.
Selective media used to detect donor strain, recipient strain, and transconjugants in transfer experiments
Antimicrobial-supplemented mediuma | Day of collection of stool sample | Use |
---|---|---|
32 μg/ml vancomycin-supplemented Enterococcosel agar | 0, 14, 35 | As negative controls to make sure that none of the volunteers were colonized by vancomycin-resistant enterococci before and after the study |
32 μg/ml vancomycin- and 32 μg/ml erythromycin-supplemented Enterococcosel agar | 0 to 7, 14, 35 | For detection of the donor strain and transconjugants |
25 μg/ml fusidic acid- and 25 μg/ml rifampin-supplemented Enterococcosel agar | 0 to 7, 14, 35 | For detection of the recipient strain and transconjugants |
25 μg/ml fusidic acid-, 25 μg/ml rifampin-, and 32 μg/ml vancomycin-supplemented Enterococcosel agar | 0 to 7, 14, 35 | For detection of transconjugants only |
Enterococcosel agar (BD Diagnostics, Sparks, MD); fusidic acid (Leo Pharmaceuticals, Ballerup, Denmark); erythromycin, rifampin, and vancomycin (Sigma-Aldrich Corp., St. Louis, MO).